Choi, E T <br/><br/>
Halofuginone, a specific collagen type I inhibitor, reduces anastomotic intimal hyperplasia.  [electronic resource] 

 -  Archives of surgery (Chicago, Ill. : 1960)  Mar 1995 
 - 257-61 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0004-0010 
<br/><br/><label>Standard No.: </label>10.1001/archsurg.1995.01430030027004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anastomosis, Surgical--adverse effects<br/>Animals<br/>Blotting, Northern<br/>Carotid Artery, Common--drug effects<br/>Cell Division--drug effects<br/>Cells, Cultured<br/>Collagen--antagonists & inhibitors<br/>Dose-Response Relationship, Drug<br/>Hyperplasia<br/>Muscle, Smooth, Vascular--drug effects<br/>Piperidines<br/>Procollagen--analysis<br/>Quinazolines--administration & dosage<br/>Quinazolinones<br/>RNA, Messenger--analysis<br/>Rabbits<br/>Tropoelastin--analysis<br/>Tunica Intima--drug effects